Closing Bell: Knight Therapeutics Inc down on Tuesday (GUD)

Knight Therapeutics Inc opened trading today at $5.65 and closed at $5.58. prices ranged from $5.49 to $5.66.

Shares decreased -2.45 percent from the previous day's close of $5.72.

Today across North America, the TSX Composite closed 0.30% at 22126.13, the S&P 500 closed 0.10% at 5572.85, the Dow Jones Industrial Average closed -0.08% at 39344.79 and the Nasdaq Composite closed 0.28% at 18403.74.

Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.

A total of 72,343 shares was traded during the last trading day, with total trades of 398. On average, Knight Therapeutics Inc has traded 41,332 shares in the last five days and 67,416 year-to-date.

Trading across the entire TSX saw 2,207 price advancers against 3,008 declines and 106 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, in the last 12 months, Knight Therapeutics Inc's shares have advanced 12.96%, while they have boosted 7.51% since the start of 2024.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $579.87 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Based on 4.00 analysts, Knight Therapeutics Inc gets an average recommendation of "Moderate Buy" according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..